Revance Therapeutics Inc

NASDAQ:RVNC  
25.04
-0.52 (-2.03%)
Equity Financing / Related, Initial Public Offerings

Revance Announces Proposed Public Offering Of Common Stock

Published: 09/12/2022 21:28 GMT
Revance Therapeutics Inc (RVNC) - Revance Announces Proposed Public Offering of Common Stock.
Revance Therapeutics Inc - a Proposed Underwritten Public Offering of $150 Million of Its Common Stock.
Revance Therapeutics - Expects to Grant Underwriters a 30-day Option to Purchase Up to an Additional 15% of Shares of Common Stock Offered in Offering.